SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC)

This study is currently recruiting participants.

Verified December 2012 by Astex Pharmaceuticals

Sponsor:

Information provided by (Responsible Party):

Astex Pharmaceuticals

ClinicalTrials.gov Identifier:

NCT01752933

First received: December 17, 2012

Last updated: December 27, 2012

Last verified: December 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	May 2014
Estimated Primary Completion Date:	October 2013 (Final data collection date for primary outcome measure)